|
Beurs gesloten -
Nasdaq
22:00:00 16-10-2026
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 37,00 USD | -2,17% |
|
-0,19% | +20,13% |
| 15/10 | Inspanningen van Revolution Medicines in Europa wijzen op ambities om kankermedicijn zelfstandig te lanceren | RE |
| 15/10 | Noordse aandelen in Noord-Amerika - Ericsson daalde 1,7 procent | FW |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6,60% | -8,56% | -10,09% | +22,40% | +59,20% | +49,38% | +63,51% | -0,71% | - | 65 mld. | |
| +0,03% | +5,56% | +10,83% | +6,38% | +12,31% | +9,10% | +69,05% | -16,32% | +233,70% | 51,2 mld. | |
| -4,09% | -0,11% | -16,18% | -3,24% | +1,51% | +2,22% | +53,15% | +185,00% | +4.783,22% | 51,19 mld. | |
| -1,53% | +2,70% | -0,94% | +29,40% | +18,41% | +30,48% | +34,12% | +7,25% | +254,54% | 43,93 mld. | |
| -1,34% | +4,12% | +4,41% | +18,28% | +21,48% | +16,64% | +115,13% | +2,97% | +1.034,52% | 41,96 mld. | |
| -5,97% | -6,22% | -9,64% | -4,40% | +123,43% | +228,95% | +454,22% | +560,33% | - | 38,14 mld. | |
| +6,53% | +8,02% | +7,60% | +10,35% | +12,54% | +16,40% | +53,41% | +7,26% | +176,07% | 33,24 mld. | |
| -0,90% | -10,49% | -3,79% | +30,34% | +53,31% | +37,09% | -3,70% | -55,94% | - | 25,2 mld. | |
| -1,07% | +2,33% | +11,50% | +33,87% | +23,43% | +19,43% | +9,98% | -12,27% | +123,99% | 22,5 mld. | |
| -2,76% | -9,54% | -11,10% | -4,12% | -7,87% | -16,58% | -9,19% | -64,59% | - | 22,03 mld. | |
| -2,96% | -4,30% | -22,35% | -11,12% | -44,69% | -41,92% | +274,59% | +263,42% | +608,39% | 21,02 mld. | |
| -1,61% | +1,05% | +0,53% | +15,01% | +10,12% | +17,12% | +156,36% | +230,59% | +1.996,51% | 17,26 mld. | |
| +3,32% | +4,18% | +4,18% | +4,18% | +193,84% | +167,65% | +388,09% | +1.614,31% | +809,55% | 15,9 mld. | |
| -0,95% | +3,96% | +6,39% | +11,28% | +41,98% | +58,55% | +185,72% | +185,20% | +440,66% | 15,42 mld. | |
| -1,14% | +1,48% | +1,80% | +11,35% | +25,42% | +25,18% | +55,83% | -27,90% | +86,96% | 15,28 mld. | |
| -0,60% | -1,74% | -5,77% | -13,70% | - | - | - | - | - | 14,79 mld. | |
| -1,99% | -0,54% | +6,56% | +33,79% | +50,47% | +68,13% | +56,37% | -25,62% | +274,95% | 14,33 mld. | |
| +3,10% | +1,66% | -2,04% | -7,07% | +15,25% | -1,40% | +455,28% | - | - | 13,77 mld. | |
| -2,83% | +3,66% | +0,29% | +0,11% | -6,61% | -8,04% | -28,34% | -38,13% | +120,16% | 13,13 mld. | |
| Gemiddelde | -1,23% | +0,05% | -1,46% | +9,64% | +33,53% | +37,69% | +132,42% | +165,58% | +841,79% | 28,17 mld. | |
| Gewogen gemiddelde per kap. | -1,83% | -0,41% | -2,36% | +11,04% | +33,21% | +39,06% | +116,82% | +126,86% | +1.105,08% |
- Beurs
- Aandelen
- Koers GMAB
- Koers GMAB
- Sector Genmab A/S
Kies jouw editie
Alle financiële informatie op nationaal niveau
